arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Lite Strategy, Inc.

LITS
$0.91 ▼ -0.05 (-4.94%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
24 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

Lite Strategy, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.1M
Dividend Yield
Revenue Growth N/M
Op. Margin None
ROIC -103.1%
FCF / Share $-3.13
Trailing P/E
Price / Book 0.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

24-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-15.95M
↓ -189.7%
Operating Margin Operating profit as % of sales
22.3%
↑ +129.6%
FCF / Share Free cash flow per share
$-3.13
↑ +58.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality
76

Dividend History

Dividend / share · sourced from SEC filings
$1.75 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 24 years · 72 quarters